| Hutchinson Regional Medical Center, Inc. | |
|
1701 E 23rd Ave Hutchinson KS 67502-1105 | |
| (620) 665-2000 | |
| (620) 513-3811 |
| Full Name | Hutchinson Regional Medical Center, Inc. |
|---|---|
| Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
| Location | 1701 E 23rd Ave, Hutchinson, Kansas |
| Authorized Official Name and Position | Benjamin Anderson (CEO) |
| Authorized Official Contact | 6206652000 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Hutchinson Regional Medical Center, Inc. 1701 E 23rd Ave Hutchinson KS 67502-1105 Ph: (620) 665-2000 | Hutchinson Regional Medical Center, Inc. 1701 E 23rd Ave Hutchinson KS 67502-1105 Ph: (620) 665-2000 |
| NPI Number | 1770880353 |
|---|---|
| Provider Enumeration Date | 02/17/2011 |
| Last Update Date | 05/03/2024 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770880353 | NPI | - | NPPES |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2015 and updates on its drug development programs.
S*BIO Pte Ltd today announced that a fourth novel, potential best-in-class compound discovered and developed by S*BIO has entered a Phase 1 clinical trial. The initiation of the study for S*BIO's oral multi-kinase inhibitor, SB1317 or TG02, in patients with advanced/refractory hematologic malignancies has triggered a payment from S*BIO's development and commercialization partner for the program, Tragara Pharmaceuticals.
Allos Therapeutics, Inc. today announced that the United States Patent and Trademark Office has issued a patent for the use of FOLOTYN™ (pralatrexate injection) for the treatment of T-cell lymphoma. U.S. Patent No. 7,622,470 was issued to Memorial-Sloan Kettering Cancer Center, SRI International and Southern Research Institute, and expires on November 24, 2025.
AbbVie, a global biopharmaceutical company, today announced that a Phase 2 trial of its investigational medicine venetoclax met its primary endpoint of achieving overall response rates in patients with relapsed/refractory or previously untreated chronic lymphocytic leukemia (CLL) with 17p deletion, according to an independent review analysis.
› Verified 1 days ago
Hutchinson Clinic, P.a., Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 Fax: 620-669-2598 | |
Summit Healthcare, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1818 E 23rd Ave, Hutchinson, KS 67502 Phone: 620-662-6000 Fax: 620-669-2394 | |
Medical Center West Rhc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1125 N Main, Hutchinson, KS 67501 Phone: 620-669-6691 Fax: 620-669-6645 | |
Hutchinson Regional Medical Center, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1701 E 23rd Ave, Hutchinson, KS 67502 Phone: 620-665-2000 | |
Cohoon Kinesiology Chiropractic And Rehab Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3007 Garden Grove Pkwy, Hutchinson, KS 67502 Phone: 620-662-6160 Fax: 620-662-5223 | |
Hutchinson Clinic, Pa, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1100 N Main St, Hutchinson, KS 67501 Phone: 620-669-2500 Fax: 620-694-4512 | |
Xpress Wellness Urgent Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1805 1/2 E 17th Ave, Hutchinson, KS 67501 Phone: 620-615-7197 |